EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease

David Goldeck, Claudia Schulte, Marcia Cristina Teixeira dos Santos, Dieter Scheller, Lilly Öttinger, Graham Pawelec, Christian Deuschle, Daniela Berg, Andre Nogueira da Costa, Walter Maetzler

Journal of Ageing and Longevity · 22.12.2022 · 3 (1) · 1-10

DOI: 10.3390/jal3010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ageing and Longevity, online erschienen am 22.12.2022. Verfasst von David Goldeck und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry for Education and Research (BMBF), UCB Pharma GmbH (Monheim, Germany), Deutsche Forschungsgemeinschaft.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune cells are thought to be involved in a destructive cycle of sterile cerebral inflammatory responses in neurodegenerative diseases such as Parkinson’s Disease (PD). Despite their peripheral origin, immune cells may enter the CNS due to impaired blood–brain barrier function and may potentially contribute to neuronal damage. Hence, specific characteristics of peripherally activated immune cells could help in understanding neurodegeneration in PD and could potentially serve as accessible disease markers. To investigate immune cell activation status, the expression of receptors for cell surface molecules CD161, NKG2A, NKG2C and NKG2D as well as chemokine receptors CCR6, CXCR2, CXCR3 and CCR5 associated with neurodegenerative diseases was investigated. The frequencies of peripheral CD8+ T-cells expressing the inhibitory and activating receptors NKG2A and NKG2C, and the activating receptor NKG2D were higher in PD patients than in healthy matched controls. The frequencies of NKG2C+CD8− cells were also higher, whereas the frequencies of CD161+ cells were not significantly different. Of the chemokine receptor-expressing cells, only the proportion of CD4−CD56+CCR5+ T-cells was higher in PD patients than in the controls. These observations support the hypothesis that an imbalance in the activation state of T-cells plays a role in the pathological processes of PD and suggest that peripheral blood immune cell phenotypes could be specific early markers for inflammation in PD.

Förderung

  • German Federal Ministry for Education and Research (BMBF)
  • UCB Pharma GmbH (Monheim, Germany)
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Goldeck, D., Schulte, C., Santos, M. C. T. D., Scheller, D., Öttinger, L., Pawelec, G., Deuschle, C., Berg, D., Costa, A. N. D., & Maetzler, W. (2022). Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease. Journal of Ageing and Longevity, 3(1), 1-10. https://doi.org/10.3390/jal3010001

Vancouver

Goldeck D, Schulte C, Santos MCTD, Scheller D, Öttinger L, Pawelec G, et al. Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease. Journal of Ageing and Longevity. 2022;3(1):1-10. doi:10.3390/jal3010001

BibTeX
@article{Goldeck2022,
  author = {Goldeck, David and Schulte, Claudia and Santos, Marcia Cristina Teixeira dos and Scheller, Dieter and Öttinger, Lilly and Pawelec, Graham and Deuschle, Christian and Berg, Daniela and Costa, Andre Nogueira da and Maetzler, Walter},
  title = {Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease},
  journal = {Journal of Ageing and Longevity},
  year = {2022},
  volume = {3},
  number = {1},
  pages = {1--10},
  doi = {10.3390/jal3010001}
}
Kostenlos starten →